Literature DB >> 33455033

Hyalinizing epithelioid tumors with OGT-FOXO fusions. A case report of a non-acral soft tissue mass harboring a novel FOXO4 gene rearrangement.

Dianne Torrence1, Lei Zhang1, Yun-Shao Sung1, Brendan C Dickson2, Cristina R Antonescu1.   

Abstract

Recurrent fusions between OGT and members of the Forkhead box (FOXO) family of genes have been recently described in three cases of hyalinizing epithelioid acral soft tissue tumors in young adults showing co-expression for EMA and CD34. Despite the lack of an established myoepithelial lineage by immunohistochemistry, these lesions have been labeled as myoepithelioma-like due to their epithelioid phenotype and sclerotic background. In this study, we report a novel FOXO4-OGT fusion identified by targeted RNA sequencing in an unclassified shoulder soft tissue mass in a 40-year-old male. The tumor showed nodular foci of increased cellularity in a uniformly hyalinized background. The neoplastic cells were mainly epithelioid and focally spindled, with eosinophilic cytoplasm and indented nuclei with mild atypia. The tumor lacked significant mitotic activity and necrosis. Immunohistochemically, the tumor showed variable positivity for EMA, pan-CK, CD34, ERG and FLI1, while it was negative for CD31, S100, SOX10, desmin, and MUC4. INI1 expression was retained. Due to its unusual histology and conflicting immunoprofile, TruSight RNA fusion panel sequencing was performed which revealed a fusion between FOXO4 exon 2 to OGT exon 2. This is the first example of a soft tissue lesion harboring OGT-related fusions occurring in a non-acral location and associated with FOXO4 gene. Its line of differentiation and biologic potential remain uncertain.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  FOXO4; OGT; epithelioid tumor; fusion

Mesh:

Substances:

Year:  2021        PMID: 33455033      PMCID: PMC8243563          DOI: 10.1002/gcc.22937

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   4.263


  31 in total

1.  AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1.

Authors:  R H Medema; G J Kops; J L Bos; B M Burgering
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

2.  Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions.

Authors:  Frederic G Barr; Stephen J Qualman; Michele H Macris; Natalya Melnyk; Elizabeth R Lawlor; Donna M Strzelecki; Timothy J Triche; Julia A Bridge; Poul H B Sorensen
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

3.  Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.

Authors:  Thomas P Lynch; Christina M Ferrer; S RaElle Jackson; Kristina S Shahriari; Keith Vosseller; Mauricio J Reginato
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

4.  O-GlcNAcylation of the Tumor Suppressor FOXO3 Triggers Aberrant Cancer Cell Growth.

Authors:  Heon Shin; Hyun-Jeong Cha; Keun Na; Min Jung Lee; Jin-Young Cho; Chae-Yeon Kim; Eun Kyung Kim; Chang Moo Kang; Hoguen Kim; Young-Ki Paik
Journal:  Cancer Res       Date:  2018-01-04       Impact factor: 12.701

5.  Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23).

Authors:  A Borkhardt; R Repp; O A Haas; T Leis; J Harbott; J Kreuder; J Hammermann; T Henn; F Lampert
Journal:  Oncogene       Date:  1997-01-16       Impact factor: 9.867

6.  NCI-MATCH launch highlights new trial design in precision-medicine era.

Authors:  Caroline McNeil
Journal:  J Natl Cancer Inst       Date:  2015-07-03       Impact factor: 13.506

7.  Myoepithelioma-like Hyalinizing Epithelioid Tumor of the Foot Harboring an OGT-FOXO1 Fusion.

Authors:  Takashi Yorozu; Kiyotaka Nagahama; Takeshi Morii; Daichi Maeda; Akihiko Yoshida; Taisuke Mori; Akimasa Hayashi; Junji Shibahara
Journal:  Am J Surg Pathol       Date:  2021-02-01       Impact factor: 6.394

8.  Myoepithelioma-like Hyalinizing Epithelioid Tumors of the Hand With Novel OGT-FOXO3 Fusions.

Authors:  Jen-Chieh Lee; Hsiu-Chu Chou; Chung-Hsi Wang; Ping-Yuan Chu; Tsung-Han Hsieh; Mei-Ling Liu; Shu-Min Hsieh; Yun-Ru Liu; Yu-Chien Kao
Journal:  Am J Surg Pathol       Date:  2020-03       Impact factor: 6.394

9.  Alternate PAX3-FOXO1 oncogenic fusion in biphenotypic sinonasal sarcoma.

Authors:  Waihay J Wong; Alexandra Lauria; Jason L Hornick; Sheng Xiao; Jonathan A Fletcher; Adrian Marino-Enriquez
Journal:  Genes Chromosomes Cancer       Date:  2015-09-10       Impact factor: 5.006

10.  MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.

Authors:  Leona A Doyle; Wei-Lien Wang; Paola Dal Cin; Dolores Lopez-Terrada; Fredrik Mertens; Alexander J F Lazar; Christopher D M Fletcher; Jason L Hornick
Journal:  Am J Surg Pathol       Date:  2012-10       Impact factor: 6.394

View more
  2 in total

1.  Expanding the spectrum of mesenchymal neoplasms with NR1D1-rearrangement.

Authors:  Maribel D Lacambra; Cristina R Antonescu; Chit Chow; Wang Kei Chiu; Elizabeth G Demicco; Peter C Ferguson; David Swanson; Ka-Fai To; Lei Zhang; Brendan C Dickson
Journal:  Genes Chromosomes Cancer       Date:  2022-03-16       Impact factor: 4.263

2.  Fusion of the Paired Box 3 (PAX3) and Myocardin (MYOCD) Genes in Pediatric Rhabdomyosarcoma.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Kristin Andersen; Marius Lund-Iversen; Svetlana Tafjord; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2021 Nov-Dec       Impact factor: 4.069

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.